<ul id="ikyum"></ul>

You are here: Industry Insights > Market News > Venezuela receives first shipment of Cuban coronavirus vaccine

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

TAYACN Drying Ammonium thiocyanate ZLG series vibration fluidized bed dryer

TAYACN Drying Nickel chloride water ZLG series vibration fluidized bed dryer

TAYACN Drying Flavoring ZLG series vibration fluidized bed dryer

TAYACN Drying Resin ZLG series vibration fluidized bed dryer

TAYACN Drying Thiourea particles ZLG series vibration fluidized bed dryer

TAYACN Drying Sodium percarbonate ZLG series vibration fluidized bed dryer

Venezuela receives first shipment of Cuban coronavirus vaccine

firstwordpharmaJune 25, 2021

Tag: Venezuela , Cuban coronavirus , Vaccine

Favorites

Venezuela’s vice president Delcy Rodriguez said the country received its first shipment of doses of Cuba's Abdala COVID-19 vaccine on Thursday, as reported in This is Money.

Venezuela receives first shipment of Cuban coronavirus vaccine

Authorities did not specify how many doses had arrived, but said that Venezuela had signed a contract to purchase 12 million doses of the vaccine.

Earlier this week, Cuba said that the three-shot Abdala vaccine had proved 92.28% effective in last-stage clinical trials.

Since February, Venezuela has received some 3.5 million doses of Russian and Chinese vaccines for its population of approximately 28 million.

Previous:OncoSec Appoints Brian Leuthner as Interim CEO

Next:Hospital Factors Tied to Greater COVID-19 Mortality in Blacks

Alzheimer’s Disease: Charting the Course from Plaques to Promise

Muhammad Farhan KhalidMay 28, 2025

New Tools，New Hope，New Frontier

InnoCare Announces First Patient Dosed in the Phase II/IIII Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Vitiligo in China

PharmaSourcesMay 16, 2025

The Phase 3 Clinical Trial of Disitamab Vedotin as a First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic ?Urothelial Carcinoma Reached its Primary Endpoints of PFS and OS

PR NewswireMay 12, 2025

Venezuela receives first shipment of Cuban coronavirus vaccine | Pharmasources.com

Illuccix China Phase 3 Study Completes Enrolment

PR NewswireMay 13, 2025

Telix Pharmaceuticals Limited announces that the pivotal Phase 3 registration study of TLX591-CDx for prostate cancer imaging in Chinese patients has completed patient enrolment.